Genetic disruption of cyclooxygenase‐2 does not improve histological or behavioral outcome after traumatic brain injury in mice
- 18 August 2008
- journal article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 86 (16) , 3605-3612
- https://doi.org/10.1002/jnr.21809
Abstract
Increasing evidence suggests a role for cyclooxygenase-2 (COX-2) in traumatic brain injury (TBI). In the present study, the role of COX-2 in TBI was investigated using COX-2 gene-disrupted (COX-2 null) mice and wild-type (WT) controls that were subjected to the controlled cortical impact (CCI) model of TBI. There was increased expression of COX-2 in ipsilateral hippocampus in WT mice subjected to CCI. CCI resulted in a significant increase in prostaglandin E(2) concentrations in WT compared with COX-2 null hippocampi. There was a significant increase in TUNEL staining of CA1 neurons 24 hr after CCI in WT, but not in COX-2 null mice, compared with sham-operated controls, which is consistent with a protective role for COX-2 in the early phase of injury after TBI. However, there was no difference in lesion volume 21 days after CCI in COX-2 null and WT mice. COX-2 gene disruption did not alter Morris water maze performance. Taken together, these results suggest only a minor role for COX-2 activity in determining outcome after TBI in mouse.Keywords
This publication has 51 references indexed in Scilit:
- Celecoxib after the onset of reperfusion reduces apoptosis in the amygdalaApoptosis, 2007
- Soluble Epoxide Hydrolase: A Novel Therapeutic Target in StrokeJournal of Cerebral Blood Flow & Metabolism, 2007
- Lipoxins and new lipid mediators in the resolution of inflammationCurrent Opinion in Pharmacology, 2006
- COX-2 inhibitors suppress lung cancer cell growth by inducing p21 via COX-2 independent signalsLung Cancer, 2006
- Resolution of inflammation: the beginning programs the endNature Immunology, 2005
- Cyclooxygenase-2-specific Inhibitor Improves Functional Outcomes, Provides Neuroprotection, and Reduces Inflammation in a Rat Model of Traumatic Brain InjuryNeurosurgery, 2005
- NS398 reduces hypoxia‐inducible factor (HIF)‐1α and HIF‐1 activity: Multiple‐level effects involving cyclooxygenase‐2 dependent and independent mechanismsInternational Journal of Cancer, 2004
- Pharmacological Treatment of Traumatic Brain InjuryCNS Drugs, 2001
- Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosisAnnals of Neurology, 2000
- Indomethacin ameliorates ischemic neuronal damage in the gerbil hippocampal CA1 sector.Stroke, 1988